Stephen Hoffman
2018 - Aadi Bioscience
In 2018, Stephen Hoffman earned a total compensation of $1.4M as Chief Executive Officer at Aadi Bioscience, a 30% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $305,500 |
|---|---|
| Option Awards | $666,595 |
| Salary | $470,000 |
| Other | $1,069 |
| Total | $1,443,164 |
Hoffman received $666.6K in option awards, accounting for 46% of the total pay in 2018.
Hoffman also received $305.5K in non-equity incentive plan, $470K in salary and $1.1K in other compensation.
Rankings
In 2018, Stephen Hoffman's compensation ranked 7,347th out of 14,244 executives tracked by ExecPay. In other words, Hoffman earned more than 48.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,347 out of 14,244 | 48th |
Division Manufacturing | 2,849 out of 5,765 | 51st |
Major group Chemicals And Allied Products | 1,072 out of 2,128 | 50th |
Industry group Drugs | 906 out of 1,817 | 50th |
Industry Pharmaceutical Preparations | 710 out of 1,391 | 49th |
Source: SEC filing on April 30, 2019.
Hoffman's colleagues
We found four more compensation records of executives who worked with Stephen Hoffman at Aadi Bioscience in 2018.
News
BODY & MIND CEO Michael Mills' 2022 pay slips 4% to $403K
February 10, 2023
BODY & MIND COO Stephen Hoffman's 2021 pay rises 2% to $462K
February 11, 2022
BODY & MIND COO Stephen Hoffman's 2020 pay jumps 106% to $451K
December 31, 2020
Aadi Bioscience CEO Stephen Hoffman's 2019 pay jumps 45% to $2.1M
April 27, 2020
BODY & MIND Director, and President of NMG Robert Hasman's 2019 pay rises 18% to $441K
December 10, 2019
Aadi Bioscience CEO Stephen Hoffman's 2018 pay falls 30% to $1.4M
April 30, 2019